Willasch, A. M. Et Al. 2019. Myeloablative conditioning for first allogeneic HSCT in pediatric all: FTBI or chemotherapy? - An update of the retrospective multicenter EBMT-PDWP study. 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , (Frankfurt, Germany), 137-138.

Willasch, A. M., Peters, C., Sedlacek, P., Dalle, J., Kitra-Roussou, V., Yesilipek, A., ... Wachowiak, J.(2019). Myeloablative conditioning for first allogeneic HSCT in pediatric all: FTBI or chemotherapy? - An update of the retrospective multicenter EBMT-PDWP study . 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) (pp.137-138). Frankfurt, Germany

Willasch, Andre Et Al. "Myeloablative conditioning for first allogeneic HSCT in pediatric all: FTBI or chemotherapy? - An update of the retrospective multicenter EBMT-PDWP study," 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 2019

Willasch, Andre M. Et Al. "Myeloablative conditioning for first allogeneic HSCT in pediatric all: FTBI or chemotherapy? - An update of the retrospective multicenter EBMT-PDWP study." 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , Frankfurt, Germany, pp.137-138, 2019

Willasch, A. M. Et Al. (2019) . "Myeloablative conditioning for first allogeneic HSCT in pediatric all: FTBI or chemotherapy? - An update of the retrospective multicenter EBMT-PDWP study." 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , Frankfurt, Germany, pp.137-138.

@conferencepaper{conferencepaper, author={Andre Manfred Willasch Et Al. }, title={Myeloablative conditioning for first allogeneic HSCT in pediatric all: FTBI or chemotherapy? - An update of the retrospective multicenter EBMT-PDWP study}, congress name={45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)}, city={Frankfurt}, country={Germany}, year={2019}, pages={137-138} }